NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/02/2023
Back to search
Official data from USPTO
TRIS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/02/2023
Trademark type
Word
Nice classes
42
Filing date
10/05/2000
Registration date
06/24/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2023
Last transaction
03/02/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2000-09-00
First use in commerce
03/15/2001
Drawing code
1
Owner type
03
Owner location
Monmouth Junction, NJ
Examiner
BOAGNI, MARY
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Tris Pharma, Inc.
Tris Pharma, Inc.
Representatives
Cathy A. Kodroff HOWSON & HOWSON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development for pharmaceuticalsneutraceuticalsdrug delivery products and biomedical products and raw materials and components used in pharmaceuticals; licensing of intellectual property; testing for others of pharmaceuticalsneutraceuticalsdrug delivery products and biomedical products
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/02/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
08/12/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/24/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/31/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/03/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/20/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/29/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/29/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/29/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
06/24/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/19/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/19/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/04/2009
PLGL
ASSIGNED TO PARALEGAL
06/24/2009
E815
TEAS SECTION 8 & 15 RECEIVED
06/18/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/29/2003
DOCK
ASSIGNED TO EXAMINER
04/22/2003
CFIT
CASE FILE IN TICRS
04/21/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/08/2003
PAPER RECEIVED
01/13/2003
IUAF
USE AMENDMENT FILED
01/09/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/09/2002
PUBO
PUBLISHED FOR OPPOSITION
04/16/2002
NPUB
NOTICE OF PUBLICATION
03/27/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2001
CNRT
NON-FINAL ACTION MAILED
03/23/2001
DOCK
ASSIGNED TO EXAMINER
03/05/2001
Continuous trademark protection
Get notified about every new filing that threatens TRIS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.